Screening of Cross-Reactive Aptamers for the Detection of 24 Quinolones by Using a Liebig's Law-Guided Parallel-Series Strategy.

Anal Chem

Key Laboratory for Analytical Science of Food Safety and Biology of MOE, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China.

Published: May 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Quinolones, a widely used class of antibiotics, present significant environmental and health concerns if they excessively remain in the environment and in food. Aptamers specific to quinolones can be applied as bioreceptors for the detection of quinolone residues in the environment and food. The quinolone family contains dozens of different individuals that share the same core structure coupled with various substituents at six different positions. The diversity and complexity of the substitution sites make it a challenge to choose a set of representative molecules that encompass all the desired sites and preserve the core molecular framework for the screening of quinolone-specific aptamers via systematic evolution of ligands by exponential enrichment (SELEX). To address this challenge, we introduce a novel parallel-series strategy guided by Liebig's law for isolating quinolone-specific cross-reactive aptamers by using the library-immobilized SELEX method. Through this approach, we successfully identified 5 aptamers (Apt.AQ01-Apt.AQ05) with high binding affinity and excellent specificity to 24 different quinolone individuals. Among them, Apt.AQ03 showcased optimal performance with affinities ranging from 0.14 to 1.07 μM across the comprehensive set of 24 quinolones, exhibiting excellent specificity against nontarget interferents. The binding performance of Apt.AQ03 was further characterized with microscale thermophoresis, circular dichroism spectra, and an exonuclease digestion assay. By using Apt.AQ03 as a bioreceptor, a fluorescence resonance energy transfer (FRET) aptasensor was developed for the detection of 24 quinolones in milk, achieving a remarkable detection limit of 14.5-21.8 ng/mL. This work not only establishes a robust and effective strategy for selecting cross-reactive aptamers applicable to other small-molecule families but also provides high-quality aptamers for developing various high-throughput and reliable methods for the detection of multiple quinolone residues in food.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.analchem.4c00616DOI Listing

Publication Analysis

Top Keywords

cross-reactive aptamers
12
detection quinolones
8
parallel-series strategy
8
environment food
8
quinolone residues
8
excellent specificity
8
aptamers
7
detection
5
quinolones
5
screening cross-reactive
4

Similar Publications

Integrated Microneedle Aptasensing Platform toward Point-of-Care Monitoring of Bacterial Infections and Treatment.

ACS Sens

August 2025

State Key Laboratory of Flexible Electronics (LoFE) & Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China.

Point-of-care (POC) monitoring of clinical inflammation biomarkers in interstitial fluid (ISF) has a great perspective on personalized healthcare. Herein, an integrated ultraswelling microneedle aptamer-recognition tester (uSMART) was developed for POC monitoring of antibiotic-resistant bacterial infections and therapeutic outcomes. The hyaluronic acid methacryloyl/sodium hyaluronate-microneedle (HAMA/SH-MN) module with excellent swelling and mechanical properties could cross the epidermis and access enough dermis ISF in a minimally invasive, painless, and rapid manner.

View Article and Find Full Text PDF

Postoperative tumor suppression via ROS scavenging, VEGF capture, and photothermal therapy using a split aptamer-loaded hydrogel.

J Control Release

August 2025

Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, POSTECH, Pohang 37673, South Korea; Medical Science and Engineering, School of Convergence Science and Technology, Pohang University of Science and Technology (POSTECH), Pohang 37673, South Korea. Electronic address: wjkim@p

Surgical resection is the primary treatment for early-stage breast cancer. However, residual tumor cells often lead to postsurgery recurrence. Current adjuvant therapies focus on eliminating residual tumors but overlook the postsurgery tumor microenvironment (TME) on residual tumor growth, resulting in limited therapeutic efficacy.

View Article and Find Full Text PDF

Exosomes in neurodegenerative diseases: Therapeutic potential and modification methods.

Neural Regen Res

February 2026

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Cancer Hospital & Institute, International Cancer Institute, Institute of Medical Technology, Peking University Health Science Center, Department of Biomedical Engineering, Peking University, Beijing, China.

In recent years, exosomes have garnered extensive attention as therapeutic agents and early diagnostic markers in neurodegenerative disease research. Exosomes are small and can effectively cross the blood-brain barrier, allowing them to target deep brain lesions. Recent studies have demonstrated that exosomes derived from different cell types may exert therapeutic effects by regulating the expression of various inflammatory cytokines, mRNAs, and disease-related proteins, thereby halting the progression of neurodegenerative diseases and exhibiting beneficial effects.

View Article and Find Full Text PDF

From bioinformatics to clinical application: A new strategy in CRP detection with peptide aptamer.

J Pharm Biomed Anal

August 2025

Guangxi University of Chinese Medicine, Nanning 530004, China; Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518035, China. Electronic address:

C-Reactive protein (CRP) is a key biomarker for evaluating inflammation levels and estimating cardiovascular risk. However, current CRP detection methods rely on monoclonal antibodies (mAb), which possess shortcomings such as a lengthy preparation cycle, high cost, and poor repeatability. To address these challenges, we explored the potential of peptide aptamers as an alternative to mAb for CRP detection.

View Article and Find Full Text PDF

Carcinoembryonic antigen (CEA) is a broad-spectrum tumor marker expressed in various human cancers. In this study, the electrode loaded with AuNPs was used to replace the traditional electrode, providing more active sites for biological probes and significantly enhancing the sensitivity of the sensor. By constructing an aptamer-antigen-aptamer "sandwich structure," highly selective detection was achieved, effectively avoiding cross-reactions.

View Article and Find Full Text PDF